Peptide record

TPDB10457

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10457
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 Peptipedia AFP-GFuse Antifungipept CAFPdb dbAMP
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, Peptipedia, AFP-GFuse, and other sources, with an available 3D structural model.
Sequence
FLPGVLRLVTKVGPAVVCAITRNC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C114H196N32O28S2
DEQHMSWY
V
2527.13
10.12
3
0
12
+3
-0.16
1.104
133.75
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.05
5
Residue Composition
number
2
A
2
R
1
N
0
D
2
C
0
E
0
Q
2
G
0
H
1
I
3
L
1
K
0
M
1
F
2
P
0
S
2
T
0
W
0
Y
5
V
Amino Acid Distribution
A: 2 R: 2 N: 1 D: 0 C: 2 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 3 K: 1 M: 0 F: 1 P: 2 S: 0 T: 2 W: 0 Y: 0 V: 5
Chemical Descriptors
24 reviewed residue count
C114H196N32O28S2 sequence-only estimate (linear, free termini)
2527.13 sequence-only estimate (linear, free termini)
10.12 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.16 sequence-only estimate (linear, free termini)
1.104 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
3.1 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 2 Activity

Activity

MIC
Antibacterial
6.3 µM

Target

B. subtilis

Source & Reference

dbAMP

Other

Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 3 Activity

Activity

MIC
Antibacterial
50 µM

Target

Candida albicans

Source & Reference

dbAMP

Other

against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 4 Activity

Activity

MIC
Antifungal
3.1 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 5 Activity

Activity

MIC
Antifungal
6.3 µM

Target

B. subtilis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 6 Activity

Activity

MIC
Antifungal
50 µM

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 7 Activity

Activity

MIC
Antiparasitic
3.1 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

NA

Other

Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 8 Activity

Activity

MIC
Antiparasitic
6.3 µM

Target

B. subtilis

Source & Reference

NA

Other

Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 9 Activity

Activity

MIC
Antiparasitic
50 µM

Target

Candida albicans

Source & Reference

NA

Other

against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 10 Activity

Activity

MIC
Antiviral
3.1 µM

Target

Staphylococcus aureus or MRSA

Source & Reference

NA

Other

Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 11 Activity

Activity

MIC
Antiviral
6.3 µM

Target

B. subtilis

Source & Reference

NA

Other

Active against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).
Evidence 12 Activity

Activity

MIC
Antiviral
50 µM

Target

Candida albicans

Source & Reference

NA

Other

against E.coli (MIC>100 uM, S. aureus or MRSA (MIC 3.1 uM), B. subtilis (MIC 6.3 uM), and C. albicans (MIC 50 uM).